Noble Financial Capital Markets, with offices around the country, defines itself as a full-service investment banking boutique, focused on private, micro-cap and small-cap emerging growth companies, with a special emphasis on Healthcare and Technology sectors. The company is known for identifying attractive growth companies and providing high quality capital markets coverage, using 10 senior research analysts covering 120 companies. In addition, Noble is a market maker in over 200 securities, with 16 senior sales and sales traders in 9 locations across the U.S. for focused institutional sales and trading.
Noble Financial’s services cover 5 primary areas:
• Investment Banking - IPOs, PIPEs & Registered Directs, Debt Offerings, Secondary Offerings, Private Equity Placements, and Recapitalizations
• Equity Research – Institutionally Driven, Fundamental Research, with access to company management and a sector focus on high-quality, under-valued, emerging growth companies with limited sponsorship
• Sales & Trading – Institutional Equity Sales, Equity Trading, Market Maker, Offices in New York, Boston, Los Angeles, St. Louis, San Francisco, and Boca Raton Florida
• Advisory – Mergers & Acquisitions, Fairness Opinions, General Advisory Services
• Merchant Banking – Principal Investments, Value Creation, Strategic Development
Healthcare represents Noble’s single largest industry focus, with equity research analysts covering the following main verticals:
• Biotechnology & Specialty Pharmaceuticals (antivirals, biosimilars, biobetters & orphan biologics, infectious disease, female health, neurology, pediatric health, stem cells, vaccines)
• Medical Technology/Devices (aesthetics, biologics, cardiology, orthopedics/spine)
• Healthcare Services (ambulatory surgery centers, chronic disease/wellness, disease management, pharmacy/PBM, care management solutions)
Current healthcare research coverage includes the following companies:
- Achillion Pharmaceuticals (ACHN)
- Acorda Therapeutics, Inc. (ACOR)
- Adcare Health Systems Inc.(ADK )
- Aeolus Pharmaceuticals (AOLS)
- Amarin Corporation (AMRN)
- American CareSource (ANSI)
- Anadys Pharmaceuticals (ANDS)
- Ardea Biosciences (RDEA)
- Auxilium Pharmaceuticals, Inc. (AUXL)
- BioMimetic (BMTI)
- BioScrip (BIOS)
- BioSpecifics Technologies Co. (BSTC)
- BioCryst Pharmaceuticals Inc. (BCRX)
- Catalyst Health Solutions (CHSI)
- Catalyst Pharmaceutical (CPRX)
- Cephalon, Inc. (CEPH)
- Cynosure (CYNO)
- Cytori Therapeutics (CYTX)
- DexCom (DXCM)
- Echo Therapeutics (ECTE)
- Edwards Lifesciences (EW)
- Exactech (EXAC)
- GenVec (GNVC)
- Hanger Orthopedic (HGR)
- Healthstream (HSTM)
- Healthways (HWAY)
- iBio, Inc. (IBIO)
- Idera Pharmaceuticals (IDRA)
- Inhibitex (INHX)
- Inovio Pharmaceuticals (INO)
- Nabi Biopharmaceuticals (NABI)
- Neuralstem, Inc. (CUR)
- Novamed (NOVA)
- Pernix Therapeutics (PTX )
- Pharmassett (VRUS)
- PharmAthene (PIP)
- PharMerica (PMC)
- PolyMedix (PYMX)
- Protalix BioTherapeutics (PLX)
- Providence Service Corp (PRSC)
- QRxPharma (QRX.AX)
- Res-Care (RCSR)
- Res-Care (RCSR)
- SIGA Technologies (SIGA)
- US Physical Therapy (USPH)
- Vical (VICL)
- Wright Medical (WMGI)
- XenoPort, Inc. (XNPT)
Other sectors covered include Business Services, Cleantech Energy, Defense Technology, Media & Entertainment.
For more information, see the company website at www.NobleFCM.com
About MissionIR:
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
